Kobo Biotech Ltd-$ MD, chairman, board of directors and AGM
BSE: 531541Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹4.11.
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹9.77 Cr4,799th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day.
- 7,436
Kobo Biotech Ltd-$ board of directors
At the end of the quarter to Jun 2024, as the company filed it; changes since are in its announcements.
- ChairpersonAJIT KAMATHRelated to the promoter
5 directors3 independent2 non-executive
- AJIT KAMATH · ChairpersonNon-executive · joined Jan 2009 · 1 listed board · 3 committee seats
- RAJENDRAKUMAR KAIMALNon-executive · joined May 2013 · 1 listed board · 1 committee seat, 1 as chair
- SUNIL PITRODAIndependent · joined Mar 2018 · reappointed Feb 2023 · 75 months as independent · 1 listed board · 1 as independent · 4 committee seats, 2 as chair
- ABHISHEK BUDDHADEVIndependent · joined Mar 2018 · reappointed Feb 2023 · 74 months as independent · 1 listed board · 1 as independent
- URJA SHAHIndependent · joined Dec 2018 · reappointed Sep 2023 · 75 months as independent · 1 listed board · 1 as independent · 1 committee seat
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 30 May 20245 of 5 present3 independent · 105 days in between
- 14 Feb 2024
Audit Committee
Chair ABHISHEK BUDDHADEV
AJIT KAMATH, SUNIL PITRODA, URJA SHAH
- 30 May 20243 of 3 present2 independent · 105 days in between
- 14 Feb 20243 of 3 present2 independent
Nomination and remuneration committee
Chair SUNIL PITRODA
URJA SHAH, RAJENDRAKUMAR KAIMAL
No meeting listed in the filing.
Stakeholders Relationship Committee
Chair RAJENDRAKUMAR KAIMAL
URJA SHAH, SUNIL PITRODA
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Compliance
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
The company's own answers in its filing.